NCT06823180View on ClinicalTrials.gov

Hydromorphone Hydrochloride Epidural Preemptive Analgesia for Postoperative Pain After Cesarean Section

PHASE4CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

March 3, 2025

Primary Completion Date

August 28, 2025

Study Completion Date

August 28, 2025

Conditions
Post-surgical Pain
Interventions
DRUG

Hydromorphone hydrochloride low dose

15min before the end of the operation, 0.1mg hydromorphone hydrochloride was injected into the epidural space in the low-dose group for preemptive analgesia.

DRUG

Hydromorphone hydrochloride high dose

15min before the end of the operation, 0.3mg hydromorphone hydrochloride was injected into the epidural space in the high-dose group for preemptive analgesia.

DRUG

0.9% sodium chloride

15min before the end of the operation, 0.9% sodium chloride injection was given in the control group.

Trial Locations (1)

330038

Jiangxi Provincial People's Hospital, Nanchang

All Listed Sponsors
lead

Liquan Liang

OTHER

NCT06823180 - Hydromorphone Hydrochloride Epidural Preemptive Analgesia for Postoperative Pain After Cesarean Section | Biotech Hunter | Biotech Hunter